- WKN: A2DUJD
- ISIN: NL0012377394
- Land: Deutschland
Nachricht vom 17.04.2018 | 19:11
Fyber N.V.: Notice of the Annual General Meeting of Shareholders of Fyber N.V. to be held on 29 May 2018
DGAP-News: Fyber N.V. / Key word(s): AGM/EGM
Notice of the Annual General Meeting of Shareholders of Fyber N.V. to be held on 29 May 2018
Fyber N.V. (the Company) invites its shareholders to its Annual General Meeting of Shareholders (AGM) to be held at the offices of Allen & Overy LLP, Apollolaan 15, 1077 AB Amsterdam, the Netherlands, on 29 May 2018, at 1:30 pm CET. The language of the meeting shall be in English.
The agenda items of the AGM will be as follows:
1) Opening and announcements
2) Annual Accounts 2017
(a) Report by the management board regarding the financial year 2017 (discussion)
(b) Corporate governance structure and compliance with Corporate Governance Code (discussion)
(c) Implementation of the remuneration policy for the management board in the financial year 2017 (discussion)
(d) Proposal to adopt the 2017 annual accounts and appropriation of losses (vote)
(e) Proposal to discharge the management board members from liability (vote)
(f) Proposal to discharge the supervisory board members from liability (vote)
3) Supervisory Board
(a) Proposal to appoint Karim Sehnaoui as a member of the Supervisory Board (vote)
(b) Proposal to extend the Term of the warrant granted to Dirk van Daele (vote)
(a) Proposal to designate the management board as the competent body to issue shares (vote)
(b) Proposal to designate the management board as the competent body to restrict or exclude pre-emptive rights upon issuing shares (vote)
(c) Proposal to designate the supervisory board as the competent body to grant members of the management board rights to subscribe for shares pursuant to the stock option plan and to restrict or exclude related pre-emptive rights (vote)
5) Any other business and close of the meeting
Registration to Vote
A confirmation by the bank in which administration the shareholder is registered for the shares must be submitted to the Company, stating that such shares were registered in his/her name at the Record Date. With this confirmation, banks are furthermore requested to include the full address details of the relevant holder in order to be able to verify the shareholding on the Record Date in an efficient manner.
The confirmation must be sent by the shareholder's bank to the Company, not later than 22 May 2018. A copy of the confirmation may be sent by e-mail to firstname.lastname@example.org. Please send the original confirmation to the address of the Company listed below. The Company will send an email confirmation to the shareholder of the registration for the AGM.
Voting by Proxy
If you intend to instruct your custodian bank for any of the above, please be aware that their deadlines could be a number of days before those mentioned above. Please check with the individual institutions as to their cut-off dates.
Registration and identification at the meeting
As of 17 April 2018 the issued share capital of the Company amounts to EUR 11,453,333.30, divided into 114,533,333 ordinary shares of EUR 0.10 each. A total of 1,966,667 shares were held by the Company itself.
For further information, please see the Company's website https://investors.fyber.com/.
All communications to the Company or the Management Board in connection with the foregoing must be addressed to the Company as follows:
The Supervisory Board and the Management Board
|Phone:||+49 30 609 855 528|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Tradegate Exchange|
|End of News||DGAP News Service|
Fyber N.V.: Notice of the Annual General Meeti ...
Fyber N.V.: Successful execution of integratio ...
Fyber N.V. extends data service by integrating ...
Fyber N.V.: Preliminary announcement of the pu ...
Fyber N.V. to present at national and internat ...
GBC im Fokus
M1 Kliniken: Geschäftsjahr über den Erwartungen
Mit dem deutlichen Anstieg auf 21 Klinikstandorte (Ende 2016: 13) hat die auf ästhetische Medizin spezialisierte M1 Kliniken AG die Basis für einen Ausbau der Umsatz- und Ertragsbasis gelegt. Hinzu kommt die bereits in Umsetzung befindliche Erschließung weiterer Umsatzströme, wie etwa die Erweiterung der Eigenmarken oder die Abdeckung der ästhetischen Zahnmedizin. Das Kursziel beläuft sich auf 18,50 € und das Rating lautet KAUFEN.
Der AKTIONÄR News
21. Mai 10:00 Geliebter Beton: Die Totgesagte
20. Mai 10:00 Geliebter Beton: Die Weitsichtigen
20. Mai 09:33 Elite Defensiv Index: Eine sichere Bank
18. Mai 2018
Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index
21. Mai 2018